These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Analysis of islet cell surface antigen reactions with islet cell surface antibodies (ICSA)]. Hakamata M; Itoh M Nihon Naibunpi Gakkai Zasshi; 1990 Jul; 66(7):700-14. PubMed ID: 2204556 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of glucose transport into rat islet cells by immunoglobulins from patients with new-onset insulin-dependent diabetes mellitus. Johnson JH; Crider BP; McCorkle K; Alford M; Unger RH N Engl J Med; 1990 Mar; 322(10):653-9. PubMed ID: 2406597 [TBL] [Abstract][Full Text] [Related]
4. Complement-fixing Islet cell antibodies from some diabetic patients alter insulin release in vitro. Sai P; Boitard C; Debray-Sachs M; Pouplard A; Assan R; Hamburger J Diabetes; 1981 Dec; 30(12):1051-7. PubMed ID: 7030831 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus. Dobersen MJ; Scharff JE; Ginsberg-Fellner F; Notkins AL N Engl J Med; 1980 Dec; 303(26):1493-8. PubMed ID: 7001237 [TBL] [Abstract][Full Text] [Related]
7. Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanisms. Rabuazzo AM; Buscema M; Vinci C; Caltabiano V; Vetri M; Forte F; Vigneri R; Purrello F Endocrinology; 1992 Oct; 131(4):1815-20. PubMed ID: 1396327 [TBL] [Abstract][Full Text] [Related]
9. The effects of islet cell surface antibodies on the metabolic function of mouse islet B cells in vitro. Dronfield DM; Peakman M; Taylor KW Acta Diabetol; 1995 Oct; 32(3):153-7. PubMed ID: 8590783 [TBL] [Abstract][Full Text] [Related]
10. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies. Hehmke B; Michaelis D; Hildmann W; Richter KV; Kohnert KD Diabetes Res; 1987 Feb; 4(2):73-7. PubMed ID: 3034475 [TBL] [Abstract][Full Text] [Related]
11. In vitro effect of exogenous insulin on insulin secretion. Studies with glucose, leucine, arginine, aminophylline and tolbutamide. Verspohl EJ; Händel M; Hagenloh I; Ammon HP Acta Diabetol Lat; 1982; 19(4):303-17. PubMed ID: 6758458 [TBL] [Abstract][Full Text] [Related]
12. Lack of specificity of islet cell surface antibodies (ICSA) in IDDM. Peterson C; Campbell IL; Harrison LC Diabetes Res Clin Pract; 1992 Jul; 17(1):33-42. PubMed ID: 1511659 [TBL] [Abstract][Full Text] [Related]
13. Islet cell antibodies (ICA), insulin autoantibodies (IAA), islet cell surface antibodies (ICSA) and C-peptide in 1031 school children in a population with a high background incidence of IDDM. Samuelsson U; Ludvigsson J; Sundkvist G Diabetes Res Clin Pract; 1994 Dec; 26(3):155-62. PubMed ID: 7736895 [TBL] [Abstract][Full Text] [Related]
14. Cyclic nucleotides in pancreatic islets. Tolbutamide- and arginine-induced insulin release. Charles MA; Lawecki J; Steiner AL; Grodsky GM Diabetes; 1976 Apr; 25(4):256-9. PubMed ID: 178555 [TBL] [Abstract][Full Text] [Related]
15. Modulation of beta-cell activity and its influence on islet cell antibody (ICA) and islet cell surface antibody (ICSA) reactivity. Björk E; Kämpe O; Grawé J; Hallberg A; Norheim I; Karlsson FA Autoimmunity; 1993; 16(3):181-8. PubMed ID: 8003613 [TBL] [Abstract][Full Text] [Related]
16. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies. Grant AM; Harrison DE; Moysey L; Smith D; Ashcroft SJ Diabetes Res; 1985 Sep; 2(5):225-9. PubMed ID: 3905186 [TBL] [Abstract][Full Text] [Related]
17. Modulation of the effect of humoral-mediated cytotoxicity on isolated rat pancreatic islets by glucose. Schröder D; Kohnert KD; Hehmke B; Besch W; Schmidt S APMIS; 1993 May; 101(5):387-94. PubMed ID: 8329200 [TBL] [Abstract][Full Text] [Related]
18. Islet cell surface antibodies by an ELISA method in diabetic and nondiabetic patients. Betterle C; Presotto F; Magrin L; Caretto A; Pedini B; Zanchetta R J Endocrinol Invest; 1991 Apr; 14(4):293-7. PubMed ID: 1865079 [TBL] [Abstract][Full Text] [Related]